CVS to offer enzyme-friendly, customized diabetes drugs for smaller pharmacies

The company, which had acquired several small diabetes adoption programs from warehouses before acquiring Memorial Sloan Kettering and Translate, said the addition of patients was due in part to a demand for its enzyme intensive blood test products.
CVS health plans were among the most popular employers of employees working in the private sector working in the last two years of the expansion known as Cost-Plus.
CVS Health said the marked shift in focus to smaller pharmacies was a just a "second sign" of cash-strapped pharmacies wanting to be considered part of cost-plus programs, which aim to reduce expenditures on contact-tracing and home healthcare for people with pre-existing conditions.
If retailers want to join COVAX, they need to use the new software architecture, CVS said.

Read more